Contraceptive pill can reduce type 2 diabetes risk in women with polycystic ovary syndrome
A study led by BHP founder-member the University of Birmingham has revealed for the first time that the contraceptive pill can reduce the risk of type 2 diabetes by over a quarter in women with polyc…
Specific cell population plays key role in effect of arthritis and people’s pain
Research led by scientists at BHP founder-member the University of Birmingham has identified a new specific population of cells that plays a key role in the affect arthritis has on the body and the s…
Triple-drug combo could prove key weapon in fight against cancer
Combining three existing drugs – a commonly-used anti-epileptic, a contraceptive steroid and a cholesterol-lowering agent – could form an effective and non-toxic treatment for a range of aggressive b…
Artificial Intelligence project aims to improve diversity and equality in AI systems
A new project has been launched across BHP members, aiming to address racial and ethical health inequalities using artificial intelligence (AI).
STANDING Together, being led by BHP founding member U…
Birmingham leads the way in delivery of a new advanced therapy in uveal melanoma
BHP founder-member University Hospitals Birmingham is the first site in the UK to treat a uveal melanoma patient with the new therapy Tebentafusp outside a clinical trial. Uveal melanoma is a rare ca…
Genetic diagnosis leads the way in childhood eye cancer treatment
Experts from BHP member Birmingham Women’s and Children’s NHS Foundation Trust have transformed the treatment of children’s eye cancer with pioneering new research.
Dr Trevor Cole and Dr Amy Gerri…